Physician profile
Benjamin Murray Smith
NPI 1740803295
$1,004.91
in general payments reported to CMS, 2019-2025
13 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $102 · 2022: $70.62 · 2023: $348 · 2024: $113 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifenet Health | $129.31 | 2023 | |
| W. L. Gore & Associates, INC. | $123.26 | 2025 | Gore Synecor Biomaterial |
| Boston Scientific Corporation | $122.72 | 2023 | |
| Medtronic, INC. | $112.52 | 2024 | Ta |
| Baxter Healthcare | $104.39 | 2025 | Floseal |
| Stryker Corporation | $102.03 | 2021 | |
| Elucent Medical | $76.44 | 2023 | |
| Davol INC. | $70.62 | 2022 | |
| Teleflex LLC | $66.59 | 2025 | Quikclot |
| Intuitive Surgical, INC. | $41.67 | 2025 | |
| Abbvie INC. | $19.61 | 2025 | |
| Gilead Sciences, INC. | $19.18 | 2023 | |
| Merck Sharp & Dohme LLC | $16.57 | 2025 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.